EW vs VG · P/E 47, rev $1.39B vs P/E 11, rev $13.77B
Edwards Lifesciences Corp (EW) versus Venture Global, Inc. (VG) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Venture Global, Inc. (VG) is a oil & gas midstream company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported VG revenue for 2025-12-31 was $13.77B. Net income was $2.73B. Revenue was up 176.9% from 2024-12-31 to 2025-12-31. VG currently screens at market cap $26.69B and trailing P/E 11.2.
EW currently screens at market cap $49.91B and trailing P/E 46.9. VG currently screens at market cap $26.69B and trailing P/E 11.2.
Not investment advice. Open the EW and VG stock pages for the full models.
Not investment advice.